Paper6340904
Clinical pharmacokinetics of metronidazole.
Ralph ED. Clin Pharmacokinet, 1983. Cited by 100 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Clinical pharmacokinetics of metronidazole. Papers, record 6340904. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6340904
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Metronidazole | Major topic |
| Administration, Oral | |
| Aging | |
| Biological Availability | |
| Humans | |
| Injections, Intravenous | |
| Kidney Diseases | |
| Kinetics | |
| Liver Diseases | |
| Oxidation-Reduction | |
| Protein Binding | |
| Suppositories |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 931,828 | Letter: Treatment of a brain abscess due to Bacteroides fragilis with metronidazole. | J Antimicrob Chemother | 1976 | https://conductscience.org/library/papers/931828 | PubMed |
| 2 | 7,319,984 | Serum metronidazole levels following rectal administration. | J Antimicrob Chemother | 1981 | https://conductscience.org/library/papers/7319984 | PubMed |
| 3 | 934,223 | The stereoselective interaction of warfarin and metronidazole in man. | N Engl J Med | 1976 | https://conductscience.org/library/papers/934223 | PubMed |
| 4 | 797,498 | Pathophysiological and disease-induced changes in drug distribution volume: pharmacokinetic implications. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/797498 | PubMed |
| 5 | 357,408 | An evaluation of metronidazole in the prophylaxis of anaerobic infections in obstetrical patients. | J Antimicrob Chemother | 1978 | https://conductscience.org/library/papers/357408 | PubMed |
| 6 | 984,809 | Susceptibility of anaerobic bacteria to 23 antimicrobial agents. | Antimicrob Agents Chemother | 1976 | https://conductscience.org/library/papers/984809 | PubMed |
| 7 | 6,783,223 | Pseudomembranous colitis after treatment with metronidazole. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6783223 | PubMed |
| 8 | 941,888 | Anaerobic meningitis and bacteremia caused by Fusobacterium species. | Am J Dis Child | 1976 | https://conductscience.org/library/papers/941888 | PubMed |
| 9 | 873,873 | Penetration of the blood brain barrier by metronidazole and tinidazole. | J Antimicrob Chemother | 1977 | https://conductscience.org/library/papers/873873 | PubMed |
| 10 | 4,524,178 | [Metronidazole-spiramycin combination. In situ concentrations and synergism compared with the minimal inhibitory concentration of the buccal flora]. | Rev Stomatol Chir Maxillofac | 1974 | https://conductscience.org/library/papers/4524178 | PubMed |
| 11 | 994,556 | A significant interaction between metronidazole and warfarin. | Mayo Clin Proc | 1976 | https://conductscience.org/library/papers/994556 | PubMed |
| 12 | 434,970 | Metronidazole therapy of anaerobic bacteremia, meningitis, and brain abscess. | Arch Intern Med | 1979 | https://conductscience.org/library/papers/434970 | PubMed |
| 13 | 1,009,357 | Metronidazole and anaerobic sepsis. | Br Med J | 1976 | https://conductscience.org/library/papers/1009357 | PubMed |
| 14 | 5,396,499 | Tinidazole and metronidazole pharmocokinetics in man and mouse. | Antimicrob Agents Chemother (Bethesda) | 1969 | https://conductscience.org/library/papers/5396499 | PubMed |
| 15 | 332,504 | Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease. | Eur J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/332504 | PubMed |
| 16 | 1,185,017 | Bioassay of metronidazole with either anaerobic or aerobic incubation. | J Infect Dis | 1975 | https://conductscience.org/library/papers/1185017 | PubMed |
| 17 | 7,117,899 | Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis. | Gut | 1982 | https://conductscience.org/library/papers/7117899 | PubMed |
| 18 | 500,521 | The pharmacokinetics of oral and intravenous metronidazole in man. | J Antimicrob Chemother | 1979 | https://conductscience.org/library/papers/500521 | PubMed |
| 19 | 7,062,220 | Pharmacokinetics and tissue distribution of metronidazole in the new born infant. | J Pediatr | 1982 | https://conductscience.org/library/papers/7062220 | PubMed |
| 20 | 4,462,462 | Microbiological agar diffusion assay for metronidazole concentrations in serum. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4462462 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 100 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,147,305 | Structure-enabled enhancement of potency in a metronidazole-benznidazole hybrid: design, synthesis, and evaluation of antitrypanosomal activity of a benzylamide-linked 5-nitroimidazole. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42147305 | PubMed |
| 41,345,821 | Metronidazole Pharmacokinetics Across Species: Meta-Analysis Integrating Allometric Scaling and Minimal Physiologically-Based Pharmacokinetic Modeling. | AAPS J | 2025 | https://conductscience.org/library/papers/41345821 | PubMed |
| 40,741,956 | Clinical pharmacokinetics of metronidazole: a systematic review and meta-analysis. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40741956 | PubMed |
| 39,968,503 | Cost-Effective Nanosensor Solutions for Ultra-Sensitive Detection of Metronidazole. | Anal Sci Adv | 2025 | https://conductscience.org/library/papers/39968503 | PubMed |
| 39,759,665 | Concurrent Onset of Osimertinib-Induced Heart Failure and Metronidazole-Induced Encephalopathy During Brain Abscess Treatment: A Report of a Rare Case. | Cureus | 2024 | https://conductscience.org/library/papers/39759665 | PubMed |
| 36,551,500 | The Blood-Brain Barrier and Pharmacokinetic/Pharmacodynamic Optimization of Antibiotics for the Treatment of Central Nervous System Infections in Adults. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36551500 | PubMed |
| 31,533,849 | The novel use of oral antibiotic monotherapy in prosthetic valve endocarditis caused by Finegoldia magna: a case study. | J Cardiothorac Surg | 2019 | https://conductscience.org/library/papers/31533849 | PubMed |
| 29,796,265 | Clinical efficacy of 12-h metronidazole dosing regimens in patients with anaerobic or mixed anaerobic infections. | Ther Adv Infect Dis | 2018 | https://conductscience.org/library/papers/29796265 | PubMed |
| 29,569,837 | Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant Women. | CPT Pharmacometrics Syst Pharmacol | 2018 | https://conductscience.org/library/papers/29569837 | PubMed |
| 25,374,704 | Metronidazole-induced encephalopathy in a patient with end-stage liver disease. | Case Reports Hepatol | 2012 | https://conductscience.org/library/papers/25374704 | PubMed |
| 22,235,170 | Oral metronidazole as antibiotic prophylaxis for patients with nonperforated appendicitis. | Clin Exp Gastroenterol | 2011 | https://conductscience.org/library/papers/22235170 | PubMed |
| 21,302,036 | The effects of an investigational antimalarial agent, NIPRD-AM1 on the single dose pharmacokinetics of metronidazole in healthy human volunteers. | Eur J Drug Metab Pharmacokinet | 2011 | https://conductscience.org/library/papers/21302036 | PubMed |
| 16,187,969 | Effects of food and formulation on the relative bioavailability of bismuth biskalcitrate, metronidazole, and tetracycline given for Helicobacter pylori eradication. | Br J Clin Pharmacol | 2005 | https://conductscience.org/library/papers/16187969 | PubMed |
| 15,561,831 | Pharmacokinetics and pharmacodynamics of intravenous levofloxacin at 750 milligrams and various doses of metronidazole in healthy adult subjects. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15561831 | PubMed |
| 15,227,388 | Anti-anaerobic antimicrobial agents: cefoxitin, cefotetan, clindamycin, and metronidazole. | Tex Heart Inst J | 1990 | https://conductscience.org/library/papers/15227388 | PubMed |
| 10,749,519 | Pharmacokinetic considerations in the eradication of Helicobacter pylori. | Clin Pharmacokinet | 2000 | https://conductscience.org/library/papers/10749519 | PubMed |
| 10,384,859 | Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. | Clin Pharmacokinet | 1999 | https://conductscience.org/library/papers/10384859 | PubMed |
| 8,794,805 | Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8794805 | PubMed |
| 6,721,462 | Pharmacokinetics of metronidazole in patients undergoing continuous ambulatory peritoneal dialysis. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6721462 | PubMed |
| 6,419,944 | Impaired elimination of metronidazole in decompensated chronic liver disease. | Br Med J (Clin Res Ed) | 1984 | https://conductscience.org/library/papers/6419944 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6340904
GET https://conductscience.org/api/papers/v1/6340904/references?page=2